| ²é¿´: 1178 | »Ø¸´: 21 | |||
[½»Á÷]
Silk Nanoparticles ÊÇʲô£¿
|
|||
|
ÕÒµ½Ò»ÆªÎÄÏ×pH-Dependent Anticancer Drug Release from Silk Nanoparticles£¬ÆäÖÐ Silk Nanoparticles²»Ã÷°×ʲôÒâ˼¡£cnkiÉϱȽ϶àÊǽâÊÍÊÇË¿ËØÄÉÃ׿ÅÁ££¬ÆäÓ¢ÎÄΪsilk fibroin nanoparticles£¬¸Ð¾õÕâÁ½¸ö²»ÊÇÒ»¸ö¸ÅÄî¡£ÊDz»ÊÇ´æÔÚʲô˿״ÄÉÃ׿ÅÁ£»ò²ÏË¿ÄÉÃ׿ÅÁ£µÈµÈ¡£Ò²²é¹ýÓ¢Îĵ쬶àÊÇsilk fibroin nanoparticles¡£²»ÖªµÀ¶þÕßÊÇ·ñΪͬһ¸ÅÄϣÍûÓÐÑо¿»òÖªµÀÕâ·½ÃæµÄǰ±²¸øÓèÖ¸µã£¬Äܹ»Ïêϸ˵һÏÂSilk NanoparticlesºÍsilk fibroin nanoparticlesµÈ¸ÅÄî¼°Ïà¹ØÎÊÌ⣬¸Ð¼¤²»¾¡¡£ ÒÔÏÂÊÇÕªÒª²¿·Ö£º Silk has traditionally been used as a suture material because of its excellent mechanical properties and biocompatibility. These properties have led to the development of different silk-based material formats for tissue engineering and regenerative medicine. Although there have been a small number of studies about the use of silk particles for drug delivery, none of these studies have assessed the potential of silk to act as a stimulus-responsive anticancer nanomedicine. This report demonstrates that an acetone precipitation of silk allows the formation of uniform silk nanoparticles (98 nm diameter, polydispersity index 0.109), with an overall negative surface charge (-33.6 +/- 5.8 mV), in a single step. Silk nanoparticles are readily loaded with doxorubicin (40 ng doxorubicin/[mu]g silk) and show pH-dependent release (pH 4.5> 6.0 > 7.4). In vitro studies with human breast cancer cell lines demonstrates that the silk nanoparticles are not cytotoxic (IC50 > 120 [mu]g mL-1) and that doxorubicin-loaded silk nanoparticles are able to overcome drug resistance mechanisms. Live cell fluorescence microscopy studies show endocytic uptake and lysosomal accumulation of silk nanoparticles. In summary, the pH-dependent drug release and lysosomal accumulation of silk nanoparticles demonstrate the ability of drug-loaded silk nanoparticles to serve as a lysosomotropic anticancer nanomedicine. |
» ²ÂÄãϲ»¶
082200£¬085606£¬085606
ÒѾÓÐ3È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©×ö¹ý·Ö×ÓʵÑé
ÒѾÓÐ9È˻ظ´
ÉúÎïÎïÀí¡¢ÉúÎﻯѧÓë·Ö×ÓÉúÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ110È˻ظ´
08¿ªÍ·
ÒѾÓÐ0È˻ظ´
ÖпÆÖÐɽҩÎï´´ÐÂÑо¿Ôº£¨Ò©´´Ôº£©ÔõôÑù£¿
ÒѾÓÐ0È˻ظ´
ÉúÎïѧ308Çóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©
ÒѾÓÐ6È˻ظ´
ÉúÎïѧ308Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÉúÎïѧ308·ÖÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
ÉòÑô»¯¹¤´óѧ»·¾³Ñ§ÔºÉúÎï¼¼ÊõÓ빤³Ì£¨ÎÞÊýѧ£©¡¢»·¾³¿ÆÑ§Ó빤³ÌµÈ¿Éµ÷¼Á
+1/480
´óÁ¬´óѧ-ÁùÅÌˮʦ·¶Ñ§ÔºÁªºÏÅàÑøÑо¿Éú½ÓÊÕµ÷¼Á
+2/252
°²»Õũҵ´óѧÀîÑǻԽÌÊÚ³ÏÕÐ »¯Ñ§¡¢Å©Ò©Ñ§¡¢Ö²±£ÀàÑо¿Éú£¬½ÓÊÕµ÷¼Á
+5/249
ɽ¶«º½¿ÕѧԺ°²È«¹¤³Ìרҵ085702µÚÈýÂÖ½ÓÊÕÑо¿Éúµ÷¼Á£¬»¶Ó×Éѯ
+1/88
½Î÷ʦ´ó»¯Ñ§¹¤³ÌѧԺµ÷¼Á½ñÍí0µã¿ª·Å£¡ ȱ¶î100¸ö£¬Ëٳ壡
+1/84
ÖÐÒ½Ò©¹ã¶«Ê¡ÊµÑéÉúÎï³ÉÏñÍŶӵ÷¼ÁÐÅÏ¢
+1/41
¶«ÄÏ´óѧ¡ªÓлú¶à¿×¹¦ÄܲÄÁÏÍŶӣ¨½ÜÇàÍŶӣ©ÕÐÊÕ AI+COFs ·½Ïò¿ÆÑÐÖúÀí
+1/38
ÎåÒØ´óѧ»·¾³Ó뻯ѧ¹¤³ÌѧԺµÚÈýÅúµ÷¼Á
+1/38
¹þ¶û±õÀí¹¤´óѧ0805²ÄÁÏ¿ÆÑ§Ó빤³Ì¡¢0856²ÄÁÏÓ뻯¹¤¡¢0703»¯Ñ§£¬½ÓÊÕµ÷¼Á
+1/37
ÕÐÊÕµ÷¼ÁÉú£¨Ò»Ö¾Ô¸07¿ªÍ·×¨Òµ£©£¬º£ÑóÉúÎïרҵ4¸öÃû¶î
+1/37
ÉòÑô¹¤Òµ´óѧʯÓÍ»¯¹¤Ñ§Ôº´«ÖÊÇ¿»¯Ñо¿ÍŶÓÕÐÊÕ˶ʿÑо¿Éúµ÷¼Á
+1/17
26É격×Ô¼ö£¨ÐÂÄÜÔ´µç³Ø·½Ïò£©
+1/14
ÖØÇ칤ÉÌ´óѧ ½ÌÓý²¿Ñо¿ÖÐÐÄÕÐÊÕ»¯¹¤/»·¾³/²ÄÁÏ/ʯÓÍ/»¯»ú·½Ïò2026Äêµ÷¼ÁÑо¿Éú
+1/12
·ðɽ´óѧ ¶¯Îï¿Æ¼¼Ñ§Ôº ÐóÄÁ »¶Ó¹ã´óѧ×Ó±¨¿¼£¡µ÷¼ÁÃû¶îÈô¸É
+1/11
ÄÏ»ª´óѧ×ÊÔ´»·¾³×¨Ë¶ºÍ»·¾³¿ÆÑ§Ó빤³Ìѧ˶Óе÷¼ÁÃû¶î
+1/9
¡¾2026¿¼Ñе÷¼Áѧ×Ó¿´¹ýÀ´£¬¹Ø×¢Äϲýº½¿Õ´óѧ¸ßÐÔ¼Û±ÈÒ»±¾¸ßУ¡¿
+1/6
ÉϺ£Ó¦Óü¼Êõ´óѧ»¯¹¤Ñ§²¿ÕÐÉúµ÷¼Á
+1/3
½Î÷¿Æ¼¼Ê¦·¶´óѧÉêÁÁ×éÕÐÑо¿Éú£¨¸ß·Ö×Ó»¯Ñ§×¨Òµ£©
+1/2
È˹¤ÖÇÄÜÓë¼ÆË㻯ѧ½»²æÑо¿·½Ïò ½ÓÊܵ÷¼Á
+1/2
ɽÎ÷´óѧÕÐÊÕ2026¼¶ÉêÇ뿼ºËÖÆ»¯Ñ§²ÄÁÏÀ಩ʿÑо¿ÉúÒ»Ãû
+1/1
7Â¥2015-11-17 19:28:16
22Â¥2016-03-28 21:50:08
¼òµ¥»Ø¸´
qinyaov2Â¥
2015-11-17 19:27
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
×£¸£
guoxintc3Â¥
2015-11-17 19:27
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

Ö§³Ö
chenleiop4Â¥
2015-11-17 19:27
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

×£¸£
yuduoj5Â¥
2015-11-17 19:27
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

xiejiaf6Â¥
2015-11-17 19:28
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

Ö§³Ö
dmbb8Â¥
2015-11-17 19:28
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
lanweip9Â¥
2015-11-17 19:28
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

fangfengw10Â¥
2015-11-17 19:28
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

xiachaz11Â¥
2015-11-17 19:28
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
×£¸£
liufeic12Â¥
2015-11-17 19:28
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
×£¸£
zhangxiaot13Â¥
2015-11-17 19:29
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

Ö§³Ö
lanmengj14Â¥
2015-11-17 19:29
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
×£¸£
marlyn15Â¥
2015-11-17 19:30
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
×£¸£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
hubaolong37016Â¥
2015-11-17 19:31
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë
°×Ñ©·ÉÑï17Â¥
2015-11-17 19:32
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
^_^ ·¢×ÔСľ³æIOS¿Í»§¶Ë
quainyni18Â¥
2015-11-17 19:33
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
×£¸£
Èýˮè19Â¥
2015-11-17 19:33
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë
chenchenyf20Â¥
2015-11-17 19:33
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë

qingxuanf21Â¥
2015-11-17 19:33
»Ø¸´
¿§·È¿¨Å©(½ð±Ò+1): лл²ÎÓë














»Ø¸´´ËÂ¥
